Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-12-09 9:43 pm Purchase |
2024-12-03 | 13G | Oculis Holding AG OCS |
Pivotal bioVenture Partners Fund I L.P. | 2,174,074 5.200% |
141,778 (+6.98%) |
Filing History |
| 2024-11-07 4:15 pm Sale |
2024-09-30 | 13G | Oculis Holding AG OCS |
Pivotal bioVenture Partners Fund I L.P. | 2,032,296 4.900% |
-382,676 (-15.85%) |
Filing History |
| 2024-02-12 9:41 pm Unchanged |
2024-02-12 | 13D | Bolt Biotherapeutics, Inc. BOLT |
Pivotal bioVenture Partners Fund I L.P. | 3,058,419 8.100% |
0 (Unchanged) |
Filing History |
| 2024-02-12 9:12 pm Purchase |
2024-02-12 | 13D | Rallybio Corporation RLYB |
Pivotal bioVenture Partners Fund I L.P. | 2,404,644 6.400% |
133,333 (+5.87%) |
Filing History |
| 2024-02-12 9:06 pm Sale |
2023-12-31 | 13G | Oculis Holding AG OCS |
Pivotal bioVenture Partners Fund I L.P. | 2,414,972 7.400% |
-617,324 (-20.36%) |
Filing History |
| 2024-02-12 9:06 pm Unchanged |
2024-02-12 | 13D | Inozyme Pharma, Inc. INZY |
Pivotal bioVenture Partners Fund I L.P. | 4,494,851 7.200% |
0 (Unchanged) |
Filing History |
| 2023-08-07 9:58 pm Purchase |
2023-08-01 | 13D | Inozyme Pharma, Inc. INZY |
Pivotal bioVenture Partners Fund I L.P. | 4,494,851 9.500% |
833,333 (+22.76%) |
Filing History |
| 2023-05-23 4:48 pm Purchase |
2023-05-12 | 13D | Inozyme Pharma, Inc. INZY |
Pivotal bioVenture Partners Fund I L.P. | 3,661,518 8.300% |
447,932 (+13.94%) |
Filing History |
| 2023-04-04 08:59 am Purchase |
2023-03-29 | 13D | Inozyme Pharma, Inc. INZY |
Pivotal bioVenture Partners Fund I L.P. | 3,213,586 7.400% |
552,432 (+20.76%) |
Filing History |
| 2023-03-15 12:53 pm Purchase |
2023-03-03 | 13G | Oculis Holding AG OCS |
Pivotal bioVenture Partners Fund I L.P. | 3,032,296 9.300% |
3,032,296 (New Position) |
Filing History |
| 2022-08-25 4:07 pm Unchanged |
2022-08-25 | 13G | Akouos, Inc. AKUS |
Pivotal bioVenture Partners Fund I L.P. | 1,794,088 4.900% |
0 (Unchanged) |
Filing History |
| 2022-04-28 4:58 pm Purchase |
2022-04-19 | 13D | Inozyme Pharma, Inc. INZY |
Pivotal bioVenture Partners Fund I L.P. | 2,661,154 6.600% |
1,070,000 (+67.25%) |
Filing History |
| 2022-02-14 09:26 am Unchanged |
2021-12-31 | 13G | Inozyme Pharma, Inc. INZY |
Pivotal bioVenture Partners Fund I L.P. | 1,591,154 6.700% |
0 (Unchanged) |
Filing History |
| 2022-02-14 09:18 am Unchanged |
2021-12-31 | 13G | Akouos, Inc. AKUS |
Pivotal bioVenture Partners Fund I L.P. | 1,794,088 5.200% |
0 (Unchanged) |
Filing History |
| 2021-08-13 5:02 pm Purchase |
2021-02-21 | 13D | Bolt Biotherapeutics, Inc. BOLT |
Pivotal bioVenture Partners Fund I L.P. | 3,058,419 8.400% |
1,166,952 (+61.70%) |
Filing History |
| 2021-08-12 5:00 pm Purchase |
2021-08-02 | 13D | Rallybio Corporation RLYB |
Pivotal bioVenture Partners Fund I L.P. | 2,271,311 7.300% |
2,271,311 (New Position) |
Filing History |
| 2021-02-17 4:56 pm Purchase |
2021-02-09 | 13D | Bolt Biotherapeutics, Inc. BOLT |
Pivotal bioVenture Partners Fund I L.P. | 1,891,467 5.500% |
1,891,467 (New Position) |
Filing History |
| 2021-02-09 5:08 pm Unchanged |
2020-12-31 | 13G | Inozyme Pharma, Inc. INZY |
Pivotal bioVenture Partners Fund I L.P. | 1,591,154 6.800% |
0 (Unchanged) |
Filing History |
| 2021-02-09 5:02 pm Unchanged |
2020-12-31 | 13G | Akouos, Inc. AKUS |
Pivotal bioVenture Partners Fund I L.P. | 1,794,088 5.200% |
0 (Unchanged) |
Filing History |
| 2021-02-09 5:02 pm Sale |
2020-12-31 | 13G | Iterum Therapeutics plc ITRM |
Pivotal bioVenture Partners Fund I L.P. | 63,006 1.200% |
-0 (-0.00%) |
Filing History |